Favipiravir CAS 259793-96-9 T-705 Nadiifinta ≥99.0% (HPLC) COVID-19 API Warshada Tayada Sare
Soo-saare leh Nadiif Sarreysa iyo Tayo Deggan
Sahayda Ganacsi ee Favipiravir iyo Dhexdhexaadiyayaasha la xidhiidha:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Magaca Kiimikada | Favipiravir |
La mid ah | T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide |
Lambarka CAS | 259793-96-9 |
Lambarka CAT | RF-API18 |
Heerka Saamiyada | Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram |
Qaanuunka molecular | C5H4FN3O2 |
Miisaanka Molecular | 157.1 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ilaa budo cad-cad |
Aqoonsiga 1H-NMR | Waafaqsan qaab-dhismeedka la soo jeediyay |
Aqoonsiga HPLC | Wakhtiga haynta ee ugu sarraysa ee diyaarinta muunadda waa in uu la mid noqdaa wakhtiga haynta ee ugu sarreysa diyaarinta heerka tixraaca |
Aqoonsiga Mass | Mass Spectrum waxay la socotaa qaab-dhismeedka la soo jeediyay |
Meesha dhalaalaysa | 188.0℃-193.0℃ |
Walxaha laxidhiidha (Aagga Caadiyan) | Mid kasta oo aan nadiif ahayn: ≤0.10% (HPLC) |
Wadarta wasakhda: ≤1.0% (HPLC) | |
Daahirnimada / Habka Falanqaynta | ≥99.0% (HPLC) |
Qoyaanka (KF) | ≤0.50% |
Hadhaaga dabka | ≤0.10% |
Biraha culus | ≤20pm |
Haraaga Xalalka | |
Methanol | ≤3000pm |
Isopropanol | ≤5000ppm |
n-Heptane | ≤5000ppm |
Ethanol | ≤5000ppm |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Walaxda Farmashiyeed ee Firfircoon (API);Daawaynta COVID-19 |
Xidhmada: Dhalo, bacda bireed ee aluminium, 25kg/ durbaan kartoon, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Favipiravir (T-705) (CAS 259793-96-9) waa mid ka mid ah 5 xeryood oo ay WHO ku talisay baaritaanka daawaynta COVID-19.Favipiravir waa xakameyn door ah oo ah fayraska RNA-ku-tiirsan RNA polymerase oo leh waxqabad ka dhan ah fayrasyada RNA badan, fayraska hargabka, fayraska Niilka Galbeed, fayraska qandhada jaalaha ah, fayraska cudurka cagaha iyo afka iyo sidoo kale flaviviruses kale, arenaviruses, bunyaviruses iyo alfaviruses.Favipiravir waa daawo ka hortag fayrus ah oo ballaaran oo ay nadiifisay Maamulaha Guud ee Dawooyinka Hindiya (DCGI) usbuucii hore "xaalad degdeg ah oo xaddidan" isticmaalka bukaannada Covid-19.Favipiravir waxaa asal ahaan soo saartay dabayaaqadii 1990-meeyadii shirkad ay markii dambe iibsatay shirkadda Japan ee Fujifilm taasoo qayb ka ahayd ka gudubka ganacsiga sawirka una gudubtay daryeelka caafimaadka.Ka dib markii lagu tijaabiyey noocyo kala duwan oo fayras ah, dawada waxaa laga ansixiyay Japan 2014 si loogu isticmaalo degdegga ah ee ka hortagga hargabka ama lagu daweeyo noocyada cusub ee hargabka.